MoneyWorks4Me

Themis Medicare - Quaterly Results

07 Nov 2022 Evaluate
The sales declined to Rs. 910.03 millions for the September 2022 quarter as compared to Rs. 1073.91 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 135.34  millions from Rs. 151.21 millions ,decline by -10.50%.Operating profit for the quarter ended September 2022 decreased to 233.18 millions as compared to 236.75 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 910.03 1073.91 -15.26 1854.38 2198.95 -15.67 3946.14 2306.70 71.07
Other Income 19.74 2.13 826.76 26.59 5.62 373.13 65.41 36.22 80.59
PBIDT 233.18 236.75 -1.51 443.63 644.99 -31.22 1021.92 535.06 90.99
Interest 23.71 20.52 15.55 46.29 47.21 -1.95 87.74 127.12 -30.98
PBDT 209.47 216.23 -3.13 397.34 597.78 -33.53 934.18 407.94 129.00
Depreciation 25.64 23.75 7.96 50.24 47.25 6.33 94.80 85.46 10.93
PBT 183.83 192.48 -4.49 347.10 550.53 -36.95 839.38 322.48 160.29
TAX 48.49 41.27 17.49 95.42 131.98 -27.70 223.81 56.28 297.67
Deferred Tax 0.79 8.77 -90.99 1.42 34.48 -95.88 56.31 56.28 0.05
PAT 135.34 151.21 -10.50 251.68 418.55 -39.87 615.57 266.20 131.24
Equity 92.00 91.99 0.01 92.00 91.99 0.01 92.00 91.88 0.13
PBIDTM(%) 25.62 22.05 16.23 23.92 29.33 -18.44 25.90 23.20 11.64
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..